Sunny Pharmtech Statistics
Total Valuation
Sunny Pharmtech has a market cap or net worth of TWD 3.60 billion. The enterprise value is 3.77 billion.
Market Cap | 3.60B |
Enterprise Value | 3.77B |
Important Dates
The next estimated earnings date is Thursday, November 14, 2024.
Earnings Date | Nov 14, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Sunny Pharmtech has 148.76 million shares outstanding. The number of shares has increased by 6.71% in one year.
Shares Outstanding | 148.76M |
Shares Change (YoY) | +6.71% |
Shares Change (QoQ) | +1.20% |
Owned by Insiders (%) | 1.66% |
Owned by Institutions (%) | 0.00% |
Float | 131.78M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 7.38 |
PB Ratio | 3.10 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 69.52, with an EV/FCF ratio of -34.17.
EV / Earnings | -74.77 |
EV / Sales | 7.78 |
EV / EBITDA | 69.52 |
EV / EBIT | n/a |
EV / FCF | -34.17 |
Financial Position
The company has a current ratio of 3.24, with a Debt / Equity ratio of 34.05.
Current Ratio | 3.24 |
Quick Ratio | 2.32 |
Debt / Equity | 34.05 |
Debt / EBITDA | 7.29 |
Debt / FCF | -3.58 |
Interest Coverage | -7.14 |
Financial Efficiency
Return on equity (ROE) is -4.83% and return on invested capital (ROIC) is -2.73%.
Return on Equity (ROE) | -4.83% |
Return on Assets (ROA) | -2.55% |
Return on Capital (ROIC) | -2.73% |
Revenue Per Employee | 3.37M |
Profits Per Employee | -350,542 |
Employee Count | 138 |
Asset Turnover | 0.29 |
Inventory Turnover | 2.59 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -32.69% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -32.69% |
50-Day Moving Average | 24.60 |
200-Day Moving Average | 29.04 |
Relative Strength Index (RSI) | 48.39 |
Average Volume (20 Days) | 151,143 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sunny Pharmtech had revenue of TWD 485.01 million and -50.48 million in losses. Loss per share was -0.34.
Revenue | 485.01M |
Gross Profit | 281.20M |
Operating Income | -67.47M |
Pretax Income | -50.48M |
Net Income | -50.48M |
EBITDA | 49.37M |
EBIT | -67.47M |
Loss Per Share | -0.34 |
Balance Sheet
The company has 221.23 million in cash and 395.71 million in debt, giving a net cash position of -174.48 million or -1.17 per share.
Cash & Cash Equivalents | 221.23M |
Total Debt | 395.71M |
Net Cash | -174.48M |
Net Cash Per Share | -1.17 |
Equity (Book Value) | 1.16B |
Book Value Per Share | 7.81 |
Working Capital | 300.55M |
Cash Flow
In the last 12 months, operating cash flow was -11.18 million and capital expenditures -99.27 million, giving a free cash flow of -110.45 million.
Operating Cash Flow | -11.18M |
Capital Expenditures | -99.27M |
Free Cash Flow | -110.45M |
FCF Per Share | -0.74 |
Margins
Gross margin is 57.98%, with operating and profit margins of -13.91% and -10.41%.
Gross Margin | 57.98% |
Operating Margin | -13.91% |
Pretax Margin | -10.41% |
Profit Margin | -10.41% |
EBITDA Margin | 10.18% |
EBIT Margin | -13.91% |
FCF Margin | -22.77% |
Dividends & Yields
Sunny Pharmtech does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -6.71% |
Shareholder Yield | -6.71% |
Earnings Yield | -1.41% |
FCF Yield | -3.07% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |